Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Directorate Changes

24 Nov 2023 09:17

RNS Number : 6130U
Jardine Matheson Hldgs Ltd
24 November 2023

24th November 2023 For immediate release

Directorate Changes Jardine Matheson Holdings Limited (the 'Company') announces the following changes to the Board:Keyu Jin will join the Board of the Company as an Independent Non-Executive Director with effect from 31st January 2024.Anthony Nightingale will step down from the Board and Audit Committee of the Company with effect from 31st January 2024.YK Pang and David Hsu will step down from the Board of the Company with effect from 31st March 2024.Our Board brings a diverse and broad range of expertise and perspectives. Keyu's appointment will further enhance the collective experience of our Board and will also increase its independence and diversity.Dr Keyu Jin Keyu Jin is a tenured professor of Economics at the London School of Economics and Political Science, where she researches globalisation and the Chinese economy. She is from Beijing, China, and holds a B.A., M.A. and PhD from Harvard University.Keyu is an independent non-executive director of Compagnie Financière Richemont SA, the second-largest luxury conglomerate, AInnovation, an AI+ manufacturing solution provider and of Stanhope Capital, one of the world's largest independent wealth management and advisory firms. Keyu is a member of China Finance 40 and a member of the economic council for the state of Qatar. She has previously advised and consulted for the World Bank, the IMF and the New York Fed.In connection with the above Board appointment, the Company advises that Keyu has held directorships in the following listed companies in the past five years:

Compagnie Financière Richemont SA

Independent Non-Executive Director

September 2017 to date

Qingdao AInnovation Technology Group Co., Ltd.

Independent Non-Executive Director

November 2021 to date

Credit Suisse Group AG

Independent Non-Executive Director

April 2022 to June 2023

Anthony Nightingale Anthony Nightingale joined the Jardines Group in 1969 and was appointed as a Director of the Company in 1994. He was Managing Director from 2006 until he retired from executive office in 2012. Anthony is also a director of DFI Retail Group Holdings Limited ('DFI') and Hongkong Land Holdings Limited ('HKLH'), and he will step down from these boards and from his position as Chairman and member of the DFI Audit Committee on 31st January 2024.YK Pang YK Pang joined the Board in 2011 and was appointed Deputy Managing Director in 2016 and Chairman of Hong Kong in 2019. He has held a number of senior executive positions across the Group, which he joined in 1984, including chief executive of Hongkong Land between 2007 and 2016. YK was a director of DFI from 2016 to 2021. He is also currently a director of HKLH and Mandarin Oriental International Limited and a member of their Audit Committees, as well as chairman of Jardine Pacific, Gammon, Hong Kong Air Cargo Terminals and Zung Fu. He will be a senior advisor to the Board and remain as Chairman of Hong Kong, while stepping down from all the other positions when he retires from executive office on 31st March 2024. David Hsu David Hsu joined the Group in 2011 and was appointed to the Board in 2016. He was chairman of Jardine Matheson (China) until his retirement from executive office in August 2022, with responsibility for supporting the Group's business developments on the Chinese mainland and in Taiwan and Macau. David will step down from the Board on 31st March 2024. Commenting on these changes, Chairman Ben Keswick said:"I would like to thank Anthony, YK and David for their many years' service to the Group and wish them every success for the future. Each of them has made a significant contribution to the growth of Jardines over the past decades, and they have all helped shape the successful Group we see today. I would also like to welcome Keyu to the Board, which will benefit from her extensive expertise and experience."

- end -

For further information, please contact:Investor enquiries:Jonathan LloydJardine Matheson Limited (852) 2843 8223This and other Group announcements can be accessed through the internet at www.jardines.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BOAEANFLAFKDFEA
Date   Source Headline
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:57 amRNSDividend
4th Apr 201910:11 amRNSAnnual Financial Report
29th Mar 20199:15 amRNSTotal Voting Rights
27th Mar 20199:12 amRNSCirc re. Scrip Dividend Scheme
26th Mar 20199:14 amRNSDirector/PDMR Shareholding
25th Mar 20199:12 amRNSBlock listing Interim Review
20th Mar 201910:53 amRNSDirector/PDMR Shareholding
7th Mar 20199:12 amRNSDirector/PDMR Shareholding
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
31st Jan 20199:07 amRNSTotal Voting Rights
30th Jan 20199:15 amRNSNotice of 2018 Final Results
24th Jan 201911:08 amRNSDirector/PDMR Shareholding
8th Jan 201910:18 amRNSDirector/PDMR Shareholding
31st Dec 20187:00 amRNSTotal Voting Rights
20th Dec 201811:32 amRNSDirector Declaration
17th Dec 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
7th Dec 20189:08 amRNSDirectorate Change
30th Nov 20189:16 amRNSTotal Voting Rights
23rd Nov 20189:10 amRNSDF Completes Partnership with Robinsons in Phl
8th Nov 20189:20 amRNSInterim Management Statement
8th Nov 20189:17 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:12 amRNSInterim Management Statement
8th Nov 20189:10 amRNSInterim Management Statement
7th Nov 20189:21 amRNS2018 Third Quarter Financial Statements
31st Oct 20189:10 amRNSTotal Voting Rights
30th Oct 201810:02 amRNSNine Months 2018 Results of PT Hero
29th Oct 20187:00 amRNSPT Astra 2018 Third Quarter Financial Statements
24th Oct 201811:31 amRNSDirector/PDMR Shareholding
11th Oct 201811:52 amRNSDirector/PDMR Shareholding
10th Oct 201810:13 amRNSDirector/PDMR Shareholding
5th Oct 201810:35 amRNSAdditional Listing
2nd Oct 201811:04 amRNSForm 8.3 - Jardine Lloyd Thompson Group plc
2nd Oct 20187:00 amRNSDF Increases Interest in Rose Pharmacy Inc to 100%
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change
1st Oct 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.